Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Diagnosis and Treatment of Non-Neurogenic Overactive Bladder in Adults

Publication Date: September 1, 2019

Last Updated: March 14, 2022

Updated Guideline Statement

Clinicians may consider combination therapy with an anti-muscarinic and β₃-adrenoceptor agonist for patients refractory to monotherapy with either anti-muscarinics or β₃-adrenoceptor agonists. (Conditional, B)

Diagnosis and Treatment of Non-Neurogenic Overactive Bladder in Adults

Updated Guideline Statement

Overview

Title

Authoring Organizations